Medication info
Amlotan Tablet 5/160 mg

Amlotan Tablet 5/160 mg

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.94mg / 1 tabletValsartan›160mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
Dark yellow oval film-coated tablet
Packaging
28 tablets (7 tablets/PTPX4)
Approval status
Active

MFDS item code 201309896 · Approved 2013.10.25 · Insurance code 640902680

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended, if possible, to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted; however, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients receiving dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients 65 years of age or older: Use caution when increasing the dose.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

Essential hypertension may require additional treatment when blood pressure control is insufficient with monotherapy of amlodipine or valsartan. In such cases, combining the two medications or other methods helps manage blood pressure more effectively to reduce the risk of cardiovascular disease. Properly controlling hypertension can prevent complications such as heart attacks or strokes. Therefore, it is used in the treatment of essential hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended, if possible, to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted; however, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients receiving dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients 65 years of age or older: Use caution when increasing the dose.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients allergic to the main ingredients of this drug or similar class drugs, pregnant or breastfeeding women, patients with severe kidney or liver dysfunction, and those with certain heart conditions should avoid taking this medication. Patients with low body sodium or fluid may experience hypotension, so their condition should be checked before taking this medication, and their blood pressure and condition should be closely monitored during treatment. Patients with elevated potassium levels or kidney issues should frequently check potassium level changes when taking this medication, and those with certain kidney diseases are at risk of worsening kidney function. Symptoms of angioedema, such as swelling of the face or neck, may occur, and if such symptoms arise, dosing should be stopped immediately. Patients with heart failure or after myocardial infarction should periodically check kidney function while taking this medication, and caution is needed in some patients with heart conditions. Dizziness or fatigue may occur while taking this medication, requiring caution during driving or operating machinery. When taken with other specific medications, the drug's effects may alter or side effects may increase, so if other medications are being taken, it is essential to consult healthcare providers. Pregnant women, women planning to become pregnant, and breastfeeding women should avoid taking this medication, and its safety and efficacy have not been established in children, so it is not recommended. Overdosage may result in hypotension or heart rhythm irregularities, so it is critical to adhere to the dosage, and if abnormal symptoms occur, immediate medical attention should be sought. Regular monitoring of blood pressure and kidney function during treatment is crucial to assess health status.

Side effects

Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, sensory abnormalities, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, oropharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, thirst, rash, erythema, hyperhidrosis, pruritus, joint swelling, low back pain, arthritis, muscle cramps, weakness, frequency of urination, polyuria, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disturbances, peripheral neuropathy, muscle tension dysregulation, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary difficulties, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuropathy, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a sealed container. Additionally, it is best to keep the drug at room temperature between 1 to 30 degrees Celsius, away from extreme heat or cold.

Appearance and packaging

Appearance

Dark yellow oval film-coated tablet

Package unit

28 tablets (7 tablets/PTPX4)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.